In France, the implementation of new prescribing rules for the sedative-hypnotic drug zolpidem led to an important and immediate decrease in use. This decline was partially compensated for by a rise in the use of a nonbenzodiazepine drug called zopiclone.
- Researchers take a stand on algorithm design for job centers: Landing a job isn’t always the right goal
- HSE Faculty of Chemistry scientists discovered new anti-cancer molecule
- SMART researchers develop new gelatin microcarrier for cell production
- Changes in subcellular traffic increase invasiveness of radioresistant cancer cells
- NUS researchers develop novel process that turns waste into nutritional supplements